Engrave Wealth Partners LLC acquired a new stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 484 shares of the company’s stock, valued at approximately $227,000. A number of […]